Want to join the conversation?
Supplier of office products $SPLS said that 2Q16 non-GAAP operating income grew 2% YoverY and non-GAAP EPS of $0.12 was flat vs. 2Q15, despite a slightly higher effective tax rate and share count. The company is accelerating its mid-market growth by leveraging its expertise and evolving its approach to customer acquisition.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?